A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01432353 · COMPLETED
Trial details
- NCT number
- NCT01432353
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.